Literature DB >> 21790621

A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery.

Nadine Shehata1, Laura Alexandra Burns, Howard Nathan, Paul Hebert, Gregory M T Hare, Dean Fergusson, C David Mazer.   

Abstract

BACKGROUND: It is important to determine the optimal hemoglobin (Hb) concentration for red blood cell (RBC) transfusion for patients undergoing cardiac surgery because increased mortality has been associated with the severity of anemia and exposure to RBCs. Because a definitive trial will require thousands of patients, and because there is variability in transfusion practices, a pilot study was undertaken to determine adherence to proposed strategies. STUDY DESIGN AND METHODS: A single-center parallel randomized controlled pilot trial was conducted in high-risk cardiac patients to assess adherence to two transfusion strategies. Fifty patients were randomly assigned either to a "restrictive" transfusion strategy (RBCs if their Hb concentration was 70 g/L or less intraoperatively during cardiopulmonary bypass [CPB] and 75 g/L or less postoperatively) or a "liberal" transfusion strategy (RBCs if their Hb concentration was 95 g/L or less during CPB and less than 100 g/L postoperatively).
RESULTS: The percentage of adherence overall was 84% in the restrictive arm and 41% in the liberal arm. Twenty-two (88%) patients were transfused 99 units of RBCs in the liberal group compared to 13 patients who were transfused 50 units in the restrictive group (p<0.01). There were no significant differences in individual adverse outcomes; however, more adverse events occurred in the restrictive group (38 vs. 15, p<0.01).
CONCLUSION: Adherence to the evaluated interventions is vital to all randomized controlled trials as it has the potential to affect outcomes. Further pilot studies are required to optimize enrollment and transfusion adherence before a definitive study is conducted.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2011        PMID: 21790621     DOI: 10.1111/j.1537-2995.2011.03236.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  21 in total

1.  Restrictive versus liberal red blood cell transfusion for cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Babikir Kheiri; Ahmed Abdalla; Mohammed Osman; Tarek Haykal; Sai Chintalapati; James Cranford; Jason Sotzen; Meghan Gwinn; Sahar Ahmed; Mustafa Hassan; Ghassan Bachuwa; Deepak L Bhatt
Journal:  J Thromb Thrombolysis       Date:  2019-02       Impact factor: 2.300

2.  Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis.

Authors:  Nadine Shehata; Nikhil Mistry; Bruno R da Costa; Tiago V Pereira; Richard Whitlock; Gerard F Curley; David A Scott; Gregory M T Hare; Peter Jüni; C David Mazer
Journal:  Eur Heart J       Date:  2019-04-01       Impact factor: 29.983

Review 3.  Risks of restrictive red blood cell transfusion strategies in patients with cardiovascular disease (CVD): a meta-analysis.

Authors:  I Cortés-Puch; B M Wiley; J Sun; H G Klein; J Welsh; R L Danner; P Q Eichacker; C Natanson
Journal:  Transfus Med       Date:  2018-04-19       Impact factor: 2.019

4.  Mortality in Critically Ill Patients Does Not Differ according to Transfusion Strategy.

Authors:  Filippo Sanfilippo; Luigi La Via; Paolo Murabito; Marinella Astuto
Journal:  Transfus Med Hemother       Date:  2021-11-12       Impact factor: 3.747

Review 5.  Transfusion thresholds for guiding red blood cell transfusion.

Authors:  Jeffrey L Carson; Simon J Stanworth; Jane A Dennis; Marialena Trivella; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Dorée; Paul C Hébert
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

Review 6.  Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis.

Authors:  Jeffrey M Rohde; Derek E Dimcheff; Neil Blumberg; Sanjay Saint; Kenneth M Langa; Latoya Kuhn; Andrew Hickner; Mary A M Rogers
Journal:  JAMA       Date:  2014-04-02       Impact factor: 56.272

7.  Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit?

Authors:  Santiago R Leal-Noval; Manuel Muñoz-Gómez; Mercedes Jiménez-Sánchez; Aurelio Cayuela; María Leal-Romero; Antonio Puppo-Moreno; Judy Enamorado; Victoria Arellano-Orden
Journal:  Intensive Care Med       Date:  2012-11-27       Impact factor: 17.440

Review 8.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

Authors:  Jeffrey L Carson; Simon J Stanworth; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Doree; Paul C Hebert
Journal:  Cochrane Database Syst Rev       Date:  2016-10-12

9.  STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management.

Authors:  Pierre Tibi; R Scott McClure; Jiapeng Huang; Robert A Baker; David Fitzgerald; C David Mazer; Marc Stone; Danny Chu; Alfred H Stammers; Tim Dickinson; Linda Shore-Lesserson; Victor Ferraris; Scott Firestone; Kalie Kissoon; Susan Moffatt-Bruce
Journal:  J Extra Corpor Technol       Date:  2021-06

10.  A multi-centre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and healthcare resource use following cardiac surgery: study protocol.

Authors:  Rachel C M Brierley; Katie Pike; Alice Miles; Sarah Wordsworth; Elizabeth A Stokes; Andrew D Mumford; Alan Cohen; Gianni D Angelini; Gavin J Murphy; Chris A Rogers; Barnaby C Reeves
Journal:  Transfus Apher Sci       Date:  2014-03-12       Impact factor: 1.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.